Clinical Trial Update: Comparison of Thrice Daily Biphasic Human Insulin With Basal Bolus Regimen in Type 2 Diabetes Mellitus Patients

View source ↗

Summary

Completed comparative clinical trial evaluating thrice-daily biphasic human insulin versus a basal-bolus insulin regimen in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Basal-Bolus Insulin regimen
• Biphasic human insulin (insulin human biphasic)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED